Feds Eyeing SciClone For Possible FCPA Violations
The U.S. Securities and Exchange Commission has launched a formal probe into SciClone Pharmaceuticals Inc., and the U.S. Department of Justice has asked for a meeting with the company regarding its...To view the full article, register now.
Already a subscriber? Click here to view full article